TY - EJOU
AU - Papadopoulos, D. P.
AU - Moyssakis, I.
AU - Makris, T. K.
AU - Poulakou, M.
AU - Stavroulakis, G.
AU - Perrea, D.
AU - Votteas, V. E.
TI - Clinical significance of matrix metalloproteinases activity in acute myocardial infarction
T2 - European Cytokine Network
PY - 2005
VL - 16
IS - 2
SN - 1952-4005
AB - Matrix metalloproteinases (MMP) degrade myocardial fibrillar collagen in acute myocardial
infarction (MI) patients. Their activity is tightly controlled in normal myocardium by a family of closely related
tissue inhibitors known as TIMP. An imbalance in their activity might contribute to post-MI remodeling. Plasma
levels of MMP-1, TIMP-1 and MMP-1/TIMP-1 complex were measured, using relevant ELISA kits, in 24 (22
males-2 females), acute MI patients with a mean age 59 ± 14 years. Blood samples were taken on admission
(0h),and 3h, 6h, 9h, 18h, 24h, 36h, 48h, 3rd, 4th, 5th, 7th, 15th, 30th days after MI. All patients underwent coronary
arteriography with ventriculography for estimation of left ventricular ejection fraction (LVEF) and extent of
coronary artery diseases, and echocardiographic study for measuring end-diastolic diameter (EDD). Ten patients
with an LVEF < 45%, an EDD > 47.5mm, and heart failure symptoms were included in group A and compared
against 12 patients with an LVEF > 45% an EDD < 47.5mm in group B.Mean plasma concentrations of MMP-1
were higher by 21% in group A (1.3 ± 0.2 ng/mL) compared to group B (1 ± 0.1 ng/mL) over the total study period.
TIMP-1 plasma concentrations showed very little difference between the 2 groups, (704 ± 213 ng/mL versus
691 ± 165 ng/mL, (6%)) Finally, plasma concentrations of MMP-1/TIMP-1 complex were lower by -36% in group
A with a mean value of 2.7 ± 0.6 ng/mL versus 3.7 ± 0.5 ng/mL in group B. Mean values for the differences were
significant at time points 0, 6, 18, 24 and 48 hours for MMP-1 (p < 0.036), and on 48h and the 4th day for
MMP-1/TIMP-1 complex (p < 0.031). Moreover, a good correlation was found between plasma concentrations of
creatine kinase (CK) and MMP-1 at 18h (r = 0.422, p = 0.041) and on the 4th day (r = 0.67, p = 0.046), and TIMP-1
on the 4th day (r = 0.67, p = 0.047). Additionally, mean values for LVEF were 35.8 ± 8.8% in group A versus
51.2 ± 1.8% (p = 0.00014) in group B. Also, the EDD in-group A was 52.1 ± 6.9 mm versus 42.9 ± 3.2 mm in group
B (p = 0.00013). In acute MI patients, increased MMP-1, with no change in TIMP-1, is associated with left
ventricular dysfunction and dilatation, suggesting that increased collagenolytic activity contributes to loss of LV
function.
KW - matrix metalloproteinases
KW - acute myocardial infarction
KW - extracellular matrix
DO -